ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 410 filers reported holding ENCOMPASS HEALTH CORP in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $420,086 | +7.8% | 6,255 | +8.7% | 0.01% | 0.0% |
| Q2 2023 | $389,671 | +29.7% | 5,755 | +3.6% | 0.01% | +25.0% |
| Q1 2023 | $300,526 | -79.4% | 5,555 | -78.6% | 0.00% | -86.2% |
| Q2 2022 | $1,457,000 | +288.5% | 25,998 | +352.6% | 0.03% | +866.7% |
| Q4 2021 | $375,000 | -89.1% | 5,744 | -87.4% | 0.00% | -90.0% |
| Q3 2021 | $3,426,000 | +412.9% | 45,654 | +433.1% | 0.03% | +400.0% |
| Q2 2021 | $668,000 | +199.6% | 8,564 | +214.4% | 0.01% | +100.0% |
| Q1 2021 | $223,000 | -53.7% | 2,724 | -65.0% | 0.00% | -81.2% |
| Q2 2020 | $482,000 | -23.0% | 7,791 | -13.8% | 0.02% | +45.5% |
| Q4 2019 | $626,000 | +174.6% | 9,042 | +151.7% | 0.01% | +83.3% |
| Q2 2019 | $228,000 | -83.5% | 3,592 | -79.7% | 0.01% | -88.0% |
| Q3 2018 | $1,383,000 | +29.7% | 17,737 | +12.7% | 0.05% | -23.1% |
| Q2 2018 | $1,066,000 | – | 15,734 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |